Meeting
2021 ASCO Annual Meeting
Association and prevalence of venous thromboembolism in cancer patients with COVID-19: A single healthcare system experience.
Authors
Aneesha Ananthula
Louisiana State University, New Orleans, LA
Aneesha Ananthula , Dat Tran , Katharine Thomas , Katie Lauren McLemore McQueen Amaker , Anh Nguyen , Soham Mahato , Brandon T Thrash , Andrew G Chapple , Suki Subbiah
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Other Checkpoint Inhibitors (Non-PD1/PDL1, Monotherapy, or Combination)
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 2627)
DOI
10.1200/JCO.2021.39.15_suppl.2627
Abstract #
2627
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Risk for vascular thromboembolic events (VaTEs) in patients (pts) with advanced urinary tract cancer (aUTC) treated with chemotherapy.
First Author: Aristotelis Bamias
Poster
2023 ASCO Annual Meeting
Apixaban versus rivaroxaban for treatment of acute deep venous thrombosis in patients with cancer.
First Author: Brittany Miles
Poster
2022 ASCO Annual Meeting
Analysis of incidence/mortality/cost for thrombotic events in hospitalized patients with lung cancer using the National Inpatient Sample database.
First Author: Kuldeepsinh Atodaria
Poster
2021 ASCO Annual Meeting
Lower respiratory tract disease (LRTD) in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study.
First Author: Dimpy P Shah